Myasthenia Gravis Association

Balance Sheet
Fiscal Year Start:
Jan 1
Assets in 2024 (Year End)
$675,665
Cash & Equivalents
98%
Receivables (Non-Related)
1%
Prepaid Expenses
<1%
Property, Plant, & Equipment (net)
<1%
Related-Party Receivables
0%
Inventories
0%
Investments
0%
Other Assets
0%
Liabilities in 2024 (Year End)
$8,235
Payables & Accruals
>99%
Grants Payable
0%
Deferred Revenue
0%
Tax-Exempt Bond Liabilities
0%
Custodial & Escrow Liabilities
0%
Notes Payable / Debt (Non-Related)
0%
Related-Party Payables
0%
Other Liabilities
0%
Assets
2023
2024
Change
Cash & Equivalents
$561,284
$659,811
+18%
Receivables (Non-Related)
$5,116
$9,284
+81%
Related-Party Receivables
-
-
-
Inventories
-
-
-
Prepaid Expenses
$4,294
$5,908
+38%
Investments
-
-
-
Property, Plant, & Equipment (net)
$1,512
$662
-56%
Other Assets
-
-
-
Total Assets
$572,206
$675,665
+18%
Liabilities
2023
2024
Change
Payables & Accruals
$3,998
$8,235
+106%
Grants Payable
-
-
-
Deferred Revenue
-
-
-
Tax-Exempt Bond Liabilities
-
-
-
Custodial & Escrow Liabilities
-
-
-
Notes Payable / Debt (Non-Related)
-
-
-
Related-Party Payables
-
-
-
Other Liabilities
-
-
-
Total Liabilities
$3,998
$8,235
+106%
Net assets
2023
2024
Change
Restricted Net Assets
-
$16,227
-
Unrestricted Net Assets
$568,208
$651,203
+15%
Net assets
2023
2024
Change
Net assets
+$568,208
+$667,430
+17%
Copyright 2026. All rights reserved to Chario Inc. (d.b.a. Impala)